UniProt ID | HYOU1_HUMAN | |
---|---|---|
UniProt AC | Q9Y4L1 | |
Protein Name | Hypoxia up-regulated protein 1 | |
Gene Name | HYOU1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 999 | |
Subcellular Localization | Endoplasmic reticulum lumen. | |
Protein Description | Has a pivotal role in cytoprotective cellular mechanisms triggered by oxygen deprivation. May play a role as a molecular chaperone and participate in protein folding.. | |
Protein Sequence | MADKVRRQRPRRRVCWALVAVLLADLLALSDTLAVMSVDLGSESMKVAIVKPGVPMEIVLNKESRRKTPVIVTLKENERFFGDSAASMAIKNPKATLRYFQHLLGKQADNPHVALYQARFPEHELTFDPQRQTVHFQISSQLQFSPEEVLGMVLNYSRSLAEDFAEQPIKDAVITVPVFFNQAERRAVLQAARMAGLKVLQLINDNTATALSYGVFRRKDINTTAQNIMFYDMGSGSTVCTIVTYQMVKTKEAGMQPQLQIRGVGFDRTLGGLEMELRLRERLAGLFNEQRKGQRAKDVRENPRAMAKLLREANRLKTVLSANADHMAQIEGLMDDVDFKAKVTRVEFEELCADLFERVPGPVQQALQSAEMSLDEIEQVILVGGATRVPRVQEVLLKAVGKEELGKNINADEAAAMGAVYQAAALSKAFKVKPFVVRDAVVYPILVEFTREVEEEPGIHSLKHNKRVLFSRMGPYPQRKVITFNRYSHDFNFHINYGDLGFLGPEDLRVFGSQNLTTVKLKGVGDSFKKYPDYESKGIKAHFNLDESGVLSLDRVESVFETLVEDSAEEESTLTKLGNTISSLFGGGTTPDAKENGTDTVQEEEESPAEGSKDEPGEQVELKEEAEAPVEDGSQPPPPEPKGDATPEGEKATEKENGDKSEAQKPSEKAEAGPEGVAPAPEGEKKQKPARKRRMVEEIGVELVVLDLPDLPEDKLAQSVQKLQDLTLRDLEKQEREKAANSLEAFIFETQDKLYQPEYQEVSTEEQREEISGKLSAASTWLEDEGVGATTVMLKEKLAELRKLCQGLFFRVEERKKWPERLSALDNLLNHSSMFLKGARLIPEMDQIFTEVEMTTLEKVINETWAWKNATLAEQAKLPATEKPVLLSKDIEAKMMALDREVQYLLNKAKFTKPRPRPKDKNGTRAEPPLNASASDQGEKVIPPAGQTEDAEPISEPEKVETGSEPGDTEPLELGGPGAEPEQKEQSTGQKRPLKNDEL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
19 | Ubiquitination | RRVCWALVAVLLADL HHHHHHHHHHHHHHH | 2.40 | - | |
51 | Ubiquitination | SMKVAIVKPGVPMEI EEEEEEECCCCCCEE | 29.91 | - | |
56 | Sulfoxidation | IVKPGVPMEIVLNKE EECCCCCCEEEECCC | 5.22 | 28465586 | |
62 | Ubiquitination | PMEIVLNKESRRKTP CCEEEECCCCCCCCC | 53.56 | - | |
75 | 2-Hydroxyisobutyrylation | TPVIVTLKENERFFG CCEEEEECCCCEECC | 49.48 | - | |
75 | Acetylation | TPVIVTLKENERFFG CCEEEEECCCCEECC | 49.48 | 26822725 | |
75 | Malonylation | TPVIVTLKENERFFG CCEEEEECCCCEECC | 49.48 | 26320211 | |
75 | Ubiquitination | TPVIVTLKENERFFG CCEEEEECCCCEECC | 49.48 | - | |
79 | Methylation | VTLKENERFFGDSAA EEECCCCEECCCHHH | 43.72 | 115480067 | |
88 | Sulfoxidation | FGDSAASMAIKNPKA CCCHHHHHHHCCHHH | 3.71 | 21406390 | |
91 | Ubiquitination | SAASMAIKNPKATLR HHHHHHHCCHHHHHH | 58.63 | 21890473 | |
91 | Ubiquitination | SAASMAIKNPKATLR HHHHHHHCCHHHHHH | 58.63 | 21890473 | |
94 | 2-Hydroxyisobutyrylation | SMAIKNPKATLRYFQ HHHHCCHHHHHHHHH | 64.49 | - | |
94 | Ubiquitination | SMAIKNPKATLRYFQ HHHHCCHHHHHHHHH | 64.49 | - | |
99 | Phosphorylation | NPKATLRYFQHLLGK CHHHHHHHHHHHHCC | 15.65 | 28152594 | |
106 | Ubiquitination | YFQHLLGKQADNPHV HHHHHHCCCCCCCCE | 42.13 | - | |
116 | Phosphorylation | DNPHVALYQARFPEH CCCCEEEEEECCCCC | 7.15 | 28152594 | |
155 | N-linked_Glycosylation | EVLGMVLNYSRSLAE HHHHHHHHHCHHHHH | 22.71 | 12754519 | |
155 | N-linked_Glycosylation | EVLGMVLNYSRSLAE HHHHHHHHHCHHHHH | 22.71 | 12754519 | |
170 | Ubiquitination | DFAEQPIKDAVITVP HHHHCCCCCEEEEHH | 46.44 | - | |
198 | Acetylation | AARMAGLKVLQLIND HHHHCCCCEEHHHCC | 39.73 | 155333 | |
198 | Ubiquitination | AARMAGLKVLQLIND HHHHCCCCEEHHHCC | 39.73 | - | |
207 | Phosphorylation | LQLINDNTATALSYG EHHHCCCCHHHHHHC | 28.40 | 25072903 | |
209 | Phosphorylation | LINDNTATALSYGVF HHCCCCHHHHHHCEE | 26.54 | 25072903 | |
212 | Phosphorylation | DNTATALSYGVFRRK CCCHHHHHHCEECCC | 19.85 | 25072903 | |
213 | Phosphorylation | NTATALSYGVFRRKD CCHHHHHHCEECCCC | 20.40 | 25072903 | |
221 | Ubiquitination | GVFRRKDINTTAQNI CEECCCCCCCCCCEE | 5.75 | - | |
222 | N-linked_Glycosylation | VFRRKDINTTAQNIM EECCCCCCCCCCEEE | 41.32 | UniProtKB CARBOHYD | |
255 | Sulfoxidation | VKTKEAGMQPQLQIR EECCCCCCCCCEEEE | 7.28 | 21406390 | |
262 | Methylation | MQPQLQIRGVGFDRT CCCCEEEEECCCCCC | 22.30 | 115480059 | |
269 | Phosphorylation | RGVGFDRTLGGLEME EECCCCCCCCHHHHH | 31.44 | - | |
275 | Sulfoxidation | RTLGGLEMELRLRER CCCCHHHHHHHHHHH | 7.65 | 21406390 | |
278 | Methylation | GGLEMELRLRERLAG CHHHHHHHHHHHHHH | 20.56 | 115480083 | |
308 | Acetylation | ENPRAMAKLLREANR HCHHHHHHHHHHHHH | 34.66 | 25953088 | |
308 | Ubiquitination | ENPRAMAKLLREANR HCHHHHHHHHHHHHH | 34.66 | - | |
311 | Ubiquitination | RAMAKLLREANRLKT HHHHHHHHHHHHHHH | 51.96 | 21890473 | |
315 | Ubiquitination | KLLREANRLKTVLSA HHHHHHHHHHHHHHC | 44.61 | - | |
369 | Phosphorylation | PVQQALQSAEMSLDE HHHHHHHHCCCCHHH | 27.35 | 20860994 | |
372 | Sulfoxidation | QALQSAEMSLDEIEQ HHHHHCCCCHHHCCE | 4.88 | 30846556 | |
373 | Phosphorylation | ALQSAEMSLDEIEQV HHHHCCCCHHHCCEE | 24.95 | 21406692 | |
376 | Ubiquitination | SAEMSLDEIEQVILV HCCCCHHHCCEEEEE | 54.44 | - | |
387 | Phosphorylation | VILVGGATRVPRVQE EEEECCCCCCHHHHH | 35.16 | 20860994 | |
398 | Ubiquitination | RVQEVLLKAVGKEEL HHHHHHHHHHCHHHH | 36.54 | 21890473 | |
398 | Acetylation | RVQEVLLKAVGKEEL HHHHHHHHHHCHHHH | 36.54 | 27452117 | |
398 | Ubiquitination | RVQEVLLKAVGKEEL HHHHHHHHHHCHHHH | 36.54 | 21890473 | |
402 | 2-Hydroxyisobutyrylation | VLLKAVGKEELGKNI HHHHHHCHHHHCCCC | 41.22 | - | |
402 | Acetylation | VLLKAVGKEELGKNI HHHHHHCHHHHCCCC | 41.22 | 26822725 | |
402 | Ubiquitination | VLLKAVGKEELGKNI HHHHHHCHHHHCCCC | 41.22 | - | |
421 | Phosphorylation | AAAMGAVYQAAALSK HHHHHHHHHHHHHHH | 7.60 | - | |
431 | Acetylation | AALSKAFKVKPFVVR HHHHHHHCCCCEEEC | 54.96 | 25953088 | |
433 | Ubiquitination | LSKAFKVKPFVVRDA HHHHHCCCCEEECCC | 33.07 | - | |
433 | Ubiquitination | LSKAFKVKPFVVRDA HHHHHCCCCEEECCC | 33.07 | - | |
443 | Phosphorylation | VVRDAVVYPILVEFT EECCCCHHHHHEEEE | 4.30 | - | |
461 | Phosphorylation | EEEPGIHSLKHNKRV HCCCCCCCCCCCCEE | 36.87 | 28450419 | |
463 | Acetylation | EPGIHSLKHNKRVLF CCCCCCCCCCCEEEE | 48.42 | 25825284 | |
463 | Ubiquitination | EPGIHSLKHNKRVLF CCCCCCCCCCCEEEE | 48.42 | - | |
515 | N-linked_Glycosylation | LRVFGSQNLTTVKLK HEEECCCCCEEEEEE | 40.84 | 16263699 | |
515 | N-linked_Glycosylation | LRVFGSQNLTTVKLK HEEECCCCCEEEEEE | 40.84 | 16263699 | |
520 | Ubiquitination | SQNLTTVKLKGVGDS CCCCEEEEEEECCHH | 42.25 | - | |
522 | Ubiquitination | NLTTVKLKGVGDSFK CCEEEEEEECCHHHH | 45.92 | - | |
527 | Phosphorylation | KLKGVGDSFKKYPDY EEEECCHHHHHCCCC | 32.79 | - | |
529 | 2-Hydroxyisobutyrylation | KGVGDSFKKYPDYES EECCHHHHHCCCCCC | 56.18 | - | |
529 | Ubiquitination | KGVGDSFKKYPDYES EECCHHHHHCCCCCC | 56.18 | - | |
530 | Acetylation | GVGDSFKKYPDYESK ECCHHHHHCCCCCCC | 61.07 | 27178108 | |
531 | Phosphorylation | VGDSFKKYPDYESKG CCHHHHHCCCCCCCC | 11.26 | 28152594 | |
537 | 2-Hydroxyisobutyrylation | KYPDYESKGIKAHFN HCCCCCCCCCHHCCC | 53.36 | - | |
537 | Ubiquitination | KYPDYESKGIKAHFN HCCCCCCCCCHHCCC | 53.36 | - | |
562 | Phosphorylation | RVESVFETLVEDSAE HHHHHHHHHHCCCHH | 25.33 | 25693802 | |
567 | Phosphorylation | FETLVEDSAEEESTL HHHHHCCCHHHHHHH | 24.87 | 29255136 | |
572 | Phosphorylation | EDSAEEESTLTKLGN CCCHHHHHHHHHHHH | 31.81 | 29691806 | |
573 | Phosphorylation | DSAEEESTLTKLGNT CCHHHHHHHHHHHHH | 41.55 | 29691806 | |
575 | Phosphorylation | AEEESTLTKLGNTIS HHHHHHHHHHHHHHH | 25.06 | 25693802 | |
580 | O-linked_Glycosylation | TLTKLGNTISSLFGG HHHHHHHHHHHHHCC | 22.04 | 55825385 | |
580 | Phosphorylation | TLTKLGNTISSLFGG HHHHHHHHHHHHHCC | 22.04 | 30622161 | |
582 | Phosphorylation | TKLGNTISSLFGGGT HHHHHHHHHHHCCCC | 20.96 | 25850435 | |
583 | Phosphorylation | KLGNTISSLFGGGTT HHHHHHHHHHCCCCC | 24.70 | 25850435 | |
589 | O-linked_Glycosylation | SSLFGGGTTPDAKEN HHHHCCCCCCCHHHC | 38.13 | 55834607 | |
589 | Phosphorylation | SSLFGGGTTPDAKEN HHHHCCCCCCCHHHC | 38.13 | 25627689 | |
590 | O-linked_Glycosylation | SLFGGGTTPDAKENG HHHCCCCCCCHHHCC | 23.57 | 55834613 | |
590 | Phosphorylation | SLFGGGTTPDAKENG HHHCCCCCCCHHHCC | 23.57 | 25159151 | |
596 | N-linked_Glycosylation | TTPDAKENGTDTVQE CCCCHHHCCCCCCHH | 58.94 | 12754519 | |
596 | N-linked_Glycosylation | TTPDAKENGTDTVQE CCCCHHHCCCCCCHH | 58.94 | 12754519 | |
600 | Phosphorylation | AKENGTDTVQEEEES HHHCCCCCCHHHHCC | 24.75 | - | |
634 | O-linked_Glycosylation | EAPVEDGSQPPPPEP CCCCCCCCCCCCCCC | 52.41 | OGP | |
634 | Phosphorylation | EAPVEDGSQPPPPEP CCCCCCCCCCCCCCC | 52.41 | 25159151 | |
722 | 2-Hydroxyisobutyrylation | KLAQSVQKLQDLTLR HHHHHHHHHHHCCHH | 46.06 | - | |
727 | Phosphorylation | VQKLQDLTLRDLEKQ HHHHHHCCHHHHHHH | 28.21 | 20068231 | |
738 | Ubiquitination | LEKQEREKAANSLEA HHHHHHHHHHHHHHH | 60.05 | - | |
742 | Phosphorylation | EREKAANSLEAFIFE HHHHHHHHHHHHHHH | 23.90 | 27050516 | |
750 | Phosphorylation | LEAFIFETQDKLYQP HHHHHHHCCCHHCCC | 31.17 | 25278378 | |
753 | Ubiquitination | FIFETQDKLYQPEYQ HHHHCCCHHCCCCHH | 39.00 | - | |
755 | Phosphorylation | FETQDKLYQPEYQEV HHCCCHHCCCCHHCC | 27.97 | 25278378 | |
759 | Phosphorylation | DKLYQPEYQEVSTEE CHHCCCCHHCCCCHH | 19.36 | 25278378 | |
763 | Phosphorylation | QPEYQEVSTEEQREE CCCHHCCCCHHHHHH | 29.37 | 25278378 | |
764 | Phosphorylation | PEYQEVSTEEQREEI CCHHCCCCHHHHHHH | 49.03 | 25278378 | |
797 | 2-Hydroxyisobutyrylation | TTVMLKEKLAELRKL HHHHHHHHHHHHHHH | 51.95 | - | |
830 | N-linked_Glycosylation | SALDNLLNHSSMFLK HHHHHHHHHCHHHHH | 35.84 | 19522481 | |
830 | N-linked_Glycosylation | SALDNLLNHSSMFLK HHHHHHHHHCHHHHH | 35.84 | 12754519 | |
832 | O-linked_Glycosylation | LDNLLNHSSMFLKGA HHHHHHHCHHHHHHC | 23.56 | 30059200 | |
845 | Sulfoxidation | GARLIPEMDQIFTEV HCCCCHHHHHHHHHH | 3.74 | 30846556 | |
850 | Phosphorylation | PEMDQIFTEVEMTTL HHHHHHHHHHCHHHH | 40.53 | - | |
854 | Sulfoxidation | QIFTEVEMTTLEKVI HHHHHHCHHHHHHHH | 4.13 | 30846556 | |
862 | N-linked_Glycosylation | TTLEKVINETWAWKN HHHHHHHHHCCHHHC | 43.57 | 12754519 | |
862 | N-linked_Glycosylation | TTLEKVINETWAWKN HHHHHHHHHCCHHHC | 43.57 | 12754519 | |
869 | N-linked_Glycosylation | NETWAWKNATLAEQA HHCCHHHCCCHHHHC | 27.70 | UniProtKB CARBOHYD | |
869 | N-linked_Glycosylation | NETWAWKNATLAEQA HHCCHHHCCCHHHHC | 27.70 | 16335952 | |
883 | 2-Hydroxyisobutyrylation | AKLPATEKPVLLSKD CCCCCCCCCEEECCH | 35.75 | - | |
883 | Acetylation | AKLPATEKPVLLSKD CCCCCCCCCEEECCH | 35.75 | 25953088 | |
883 | Malonylation | AKLPATEKPVLLSKD CCCCCCCCCEEECCH | 35.75 | 26320211 | |
889 | 2-Hydroxyisobutyrylation | EKPVLLSKDIEAKMM CCCEEECCHHHHHHH | 63.80 | - | |
894 | 2-Hydroxyisobutyrylation | LSKDIEAKMMALDRE ECCHHHHHHHHHHHH | 19.20 | - | |
894 | Acetylation | LSKDIEAKMMALDRE ECCHHHHHHHHHHHH | 19.20 | 26822725 | |
900 | Methylation | AKMMALDREVQYLLN HHHHHHHHHHHHHHH | 47.00 | 115480075 | |
904 | Phosphorylation | ALDREVQYLLNKAKF HHHHHHHHHHHHHCC | 20.52 | 28152594 | |
908 | 2-Hydroxyisobutyrylation | EVQYLLNKAKFTKPR HHHHHHHHHCCCCCC | 53.58 | - | |
922 | N-linked_Glycosylation | RPRPKDKNGTRAEPP CCCCCCCCCCCCCCC | 68.17 | UniProtKB CARBOHYD | |
931 | N-linked_Glycosylation | TRAEPPLNASASDQG CCCCCCCCCCCCCCC | 37.31 | 17623646 | |
931 | N-linked_Glycosylation | TRAEPPLNASASDQG CCCCCCCCCCCCCCC | 37.31 | 12754519 | |
933 | O-linked_Glycosylation | AEPPLNASASDQGEK CCCCCCCCCCCCCCC | 27.51 | 30059200 | |
948 | Phosphorylation | VIPPAGQTEDAEPIS CCCCCCCCCCCCCCC | 34.61 | 26091039 | |
955 | Phosphorylation | TEDAEPISEPEKVET CCCCCCCCCCCCCCC | 58.79 | 29507054 | |
962 | Phosphorylation | SEPEKVETGSEPGDT CCCCCCCCCCCCCCC | 49.33 | 25627689 | |
964 | O-linked_Glycosylation | PEKVETGSEPGDTEP CCCCCCCCCCCCCCC | 48.30 | OGP | |
964 | Phosphorylation | PEKVETGSEPGDTEP CCCCCCCCCCCCCCC | 48.30 | 25627689 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of HYOU1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of HYOU1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of HYOU1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
RPAC1_HUMAN | POLR1C | physical | 22939629 | |
NUP37_HUMAN | NUP37 | physical | 22939629 | |
ARMX3_HUMAN | ARMCX3 | physical | 22863883 | |
BCAR1_HUMAN | BCAR1 | physical | 22863883 | |
BIN1_HUMAN | BIN1 | physical | 22863883 | |
KI13A_HUMAN | KIF13A | physical | 22863883 | |
MCM2_HUMAN | MCM2 | physical | 22863883 | |
MSH6_HUMAN | MSH6 | physical | 22863883 | |
XRCC5_HUMAN | XRCC5 | physical | 22863883 | |
XRCC6_HUMAN | XRCC6 | physical | 22863883 | |
DJB11_HUMAN | DNAJB11 | physical | 26344197 | |
DNJC7_HUMAN | DNAJC7 | physical | 26344197 | |
ERF1_HUMAN | ETF1 | physical | 26344197 | |
HXK1_HUMAN | HK1 | physical | 26344197 | |
HXK2_HUMAN | HK2 | physical | 26344197 | |
NU205_HUMAN | NUP205 | physical | 26344197 | |
SE1L1_HUMAN | SEL1L | physical | 27030672 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins."; Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,Schiess R., Aebersold R., Watts J.D.; Nat. Biotechnol. 27:378-386(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-515, AND MASSSPECTROMETRY. | |
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-515; ASN-596; ASN-830;ASN-862 AND ASN-931, AND MASS SPECTROMETRY. | |
"Elucidation of N-glycosylation sites on human platelet proteins: aglycoproteomic approach."; Lewandrowski U., Moebius J., Walter U., Sickmann A.; Mol. Cell. Proteomics 5:226-233(2006). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-515, AND MASSSPECTROMETRY. | |
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-515; ASN-830; ASN-869 ANDASN-931, AND MASS SPECTROMETRY. | |
"Identification and quantification of N-linked glycoproteins usinghydrazide chemistry, stable isotope labeling and mass spectrometry."; Zhang H., Li X.-J., Martin D.B., Aebersold R.; Nat. Biotechnol. 21:660-666(2003). Cited for: GLYCOSYLATION AT ASN-155; ASN-515; ASN-596; ASN-830; ASN-862 ANDASN-931. |